Viking Therapeutics' weight loss drug VK2735 may challenge Novo Nordisk and Eli Lilly's dominance in the obesity drug space ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) ...

Kristen Fischer is a journalist who has covered health news for more than a decade. Her work has appeared in outlets like Healthline, Prevention, and HealthDay. While taking GLP-1 medications like ...

Related Ozempic, Wegovy might help ease knee arthritis pain Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity Ozempic, Wegovy might lower Alzheimer's risk in Type 2 diabetics But ...

Compounded GLP-1s for Weight Loss: What Are They and Are They Safe? GLP-1s (glucagon-like peptide-1 receptor agonists) are medications used to treat type 2 diabetes and obesity. You’ve probably ...

(MENAFN- Zex PR Wire) Michigan, US, 7th November 2024, ZEX PR WIRE , With the rise of GLP-1 medications, such as Wegovy and Ozempic, making waves in the weight loss industry, Doctors Medical ...

Separately on Monday, Novo announced a partnership with Ascendis Pharma (ASND) to develop a once-monthly GLP-1 med. Novo and ...